582 Companies
C4X Discovery Holdings plc, a British drug discovery company, is making waves in the industry with its innovative platforms and promising product pipeline. At the core of the company's technology i...
C4X Discovery Annual Report 2023Liquidia Corporation, a prominent biopharmaceutical firm operating within the United States, has recently committed itself to the development, manufacturing, and commercialization of numerous produ...
Liquidia Corp Annual Report 2023Seattle-based NanoString Technologies, Inc. is making significant strides in the development and sale of technology for scientific and clinical information in the fields of genomics and proteomics....
NanoString Annual Report 2020Xencor, a clinical stage biopharmaceutical firm, is making strides in the discovery and development of monoclonal antibody and cytokine therapeutics aimed at treating cancer and autoimmune diseases...
Xencor Annual Report 2023Oncternal Therapeutics, Inc. (ONCT), a clinical-stage biopharmaceutical company, is specializing in developing oncology therapies for cancers that have critical unmet medical needs. Amongst its cli...
Oncternal Therapeutics, Inc. Annual Report 2023Biotech firm Cocrystal Pharma is dedicated to researching and creating antiviral therapeutics for serious and chronic viral illnesses. With a focus on hepatitis C virus (HCV), influenza, coronaviru...
Cocrystal Pharma, Inc. Annual Report 2023Sherwood, Oregon-based Entia Biosciences, Inc. is a company dedicated to the development, production, and distribution of dietary supplements, nutraceuticals, and medical foods products in the Unit...
Ergomed Annual Report 2021Alder Biopharmaceuticals is a biopharmaceutical company that focuses on discovering, developing, and commercializing therapeutic antibodies that have the potential to revolutionize current treatmen...
Alder Biopharmaceuticals Inc Annual Report 2017Retrophin, a biopharmaceutical company, has a focus on developing and providing innovative treatments for individuals with rare diseases. Its primary product candidate in late-stage development is ...
Retrophin, Inc. Annual Report 2018NuCana plc, a clinical-stage biopharmaceutical firm focused on developing cancer therapies, is utilizing its proprietary ProTide technology to conceptualize new treatments. The company's primary dr...
NuCana plc Annual Report 2023Arix Bioscience is a venture capital company with a focus on the cutting-edge advances in the life sciences industry. The company collaborates with innovative entrepreneurs to invest in and build b...
Arix Bioscience Annual Report 2021Siren Gold Limited is a gold exploration company based in Western Perth, Australia. The company's primary focus is on the Reefton goldfield on the South Island of New Zealand, where it holds intere...
Siren Gold Limited Annual Report 2023California-based XOMA Corporation serves as a biotech royalty aggregator across Europe, Asia Pacific and the United States. Their mission is to drive enhancements in human health by supporting biot...
XOMA Ltd. Annual Report 2023Revolution Medicines, Inc., a clinical-stage precision oncology company, is revolutionizing cancer treatment through its innovative therapies designed to obstruct frontier targets in RAS-addicted c...
Revolution Medicines Annual Report 2023Brickell Biotech is a clinical-stage pharmaceutical company that is working to develop innovative prescription therapeutics that can treat skin diseases. The company's focus is on debilitating skin...
Brickell Biotech, Inc. Annual Report 2020